Next-Generation KRAS G12C Inhibitor Shows ‘Robust’ Efficacy in Advanced Lung Cancer
(MedPage Today) -- SAN DIEGO -- Treatment with investigational elisrasib, a next-generation KRAS G12C inhibitor, showed efficacy in patients with ...
(MedPage Today) -- SAN DIEGO -- Treatment with investigational elisrasib, a next-generation KRAS G12C inhibitor, showed efficacy in patients with ...
© 2025 PickByDoc. All rights reserved. PickByDoc is a medical news & health awareness platform.